Instylla

About:

Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology.

Website: http://www.instylla.com/

Top Investors: Delos Capital, Sparta Group, Ascension Ventures, Catalyst Health Ventures, Incept LLC

Description:

Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology. It is a Bedford, Massachusetts-based company. independently held firm with the major objective of developing next-generation liquid embolics for the radiology department. with early medical applications in peripheral hemostasis and interventional oncology. The EmbraceTM Hydrogel Embolic System, the company's initial product, and persistent embolization in these clinical situations.

Total Funding Amount:

$63.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2017-01-01

Founders:

Amarpreet Sawhney

Number of Employees:

11-50

Last Funding Date:

2023-08-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai